Does iron deficiency impair thyroid hormone production and T4-to-T3 conversion leading to low T3 physiology?

The synthesis of clinical and mechanistic research indicates that iron deficiency directly impairs thyroid hormone metabolism, leading to reduced synthesis in the gland and diminished peripheral conversion of thyroxine (T4) to the more biologically active triiodothyronine (T3).

Impact on thyroid hormone synthesis

Iron is a critical structural component of the heme prosthetic group in thyroid peroxidase (TPO), the primary enzyme responsible for thyroid hormone production.

• Mechanistic role: TPO catalyzes iodide organification and the coupling of iodotyrosine residues to form T4 and T3. Because TPO is a heme-dependent enzyme, iron deficiency reduces its catalytic capacity, directly limiting the thyroid's ability to produce hormones.
• Clinical markers: Studies in adult populations show that iron deficiency (serum ferritin <30 ng/mL) is consistently associated with higher TSH and lower free T4 (fT4) and T3 levels.
• Enzymatic impairment: Low iron status reduces TPO activity and has been linked to an increased risk of TPO antibody (TPOAb) positivity, which further compromises glandular function.

Peripheral conversion and low T3 physiology

Beyond glandular production, iron status significantly influences the peripheral metabolism of thyroid hormones, specifically the conversion of T4 into T3.

• Deiodinase function: The conversion of T4 to T3 is mediated by deiodinase enzymes (DIO1 and DIO2). While these are selenoproteins, iron is required for their optimal expression and activity. Iron deficiency (ID) correlates with lower free T3 (fT3) levels and a reduced fT3/fT4 ratio, indicative of impaired conversion.
• Low T3 risk: Clinical data demonstrate that iron-deficient individuals have a significantly higher risk (OR ≈ 1.8) of developing low T3 levels compared to iron-sufficient controls. This creates a state of "low T3 physiology," where despite potentially normal TSH and T4 levels, the body lacks sufficient active T3.
• Cellular evidence: In neuronal models, cellular iron depletion triggers a compensatory up-regulation of Dio2 mRNA, signaling that the cells are attempting to overcome a functional intracellular T3 deficit.

Clinical implications

For patients, particularly post-menopausal women who may have histories of iron depletion or altered absorption, maintaining optimal iron status is essential for euthyroid function.

• Evidence suggests that even in patients with normal TSH, low iron status can result in significantly lower free T3 levels.
• Research indicates that iron supplementation in deficient individuals can improve thyroid hormone profiles, specifically by increasing T3 concentrations and lowering TSH.

Bottom line

Iron deficiency impairs thyroid hormone synthesis by reducing heme-dependent TPO activity and disrupts the peripheral conversion of T4 to T3. This dual mechanism contributes to low T3 physiology, which may manifest as functional hypothyroidism even when standard TSH levels appear within range.